Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States.

cervical cancer human papillomavirus mortality oropharyngeal cancer productivity loss

Journal

Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579

Informations de publication

Date de publication:
2021
Historique:
received: 06 04 2021
accepted: 25 06 2021
entrez: 12 8 2021
pubmed: 13 8 2021
medline: 13 8 2021
Statut: epublish

Résumé

[This corrects the article DOI: 10.3389/fpubh.2020.624092.].

Identifiants

pubmed: 34381752
doi: 10.3389/fpubh.2021.691634
pmc: PMC8350760
doi:

Types de publication

Published Erratum

Langues

eng

Sous-ensembles de citation

IM

Pagination

691634

Commentaires et corrections

Type : ErratumFor

Informations de copyright

Copyright © 2021 Priyadarshini, Prabhu, Snedecor, Corman, Kuter, Nwankwo, Chirovsky and Myers.

Auteurs

Masoom Priyadarshini (M)

Pharmerit - an OPEN Health Company, Bethesda, MD, United States.

Vimalanand S Prabhu (VS)

Merck & Co. Inc., Kenilworth, NJ, United States.

Sonya J Snedecor (SJ)

Pharmerit - an OPEN Health Company, Bethesda, MD, United States.

Shelby Corman (S)

Pharmerit - an OPEN Health Company, Bethesda, MD, United States.

Barbara J Kuter (BJ)

Merck & Co. Inc., Kenilworth, NJ, United States.

Chizoba Nwankwo (C)

Merck & Co. Inc., Kenilworth, NJ, United States.

Diana Chirovsky (D)

Merck & Co. Inc., Kenilworth, NJ, United States.

Evan Myers (E)

Division of Women's Community and Population Health, Department of Obstetrics & Gynecology, Duke University School of Medicine, Durham, NC, United States.

Classifications MeSH